In accordance with our prior analyses, we would like to verify the possible prognosis role of GAL‐3 on NSCLC patients, focusing on early‐stage due to the tumor resection for these patients offers the best hope of cure, however, recurrences rates post‐surgery remaining extremely increased [57]. The gene discussed is LGALS3; the disease is non-small cell lung carcinoma.